FMO2 and chronic kidney disease: In addition to abovementioned genes, many genes that are rarely described in CKD progression were found differentially expressed in the rapid versus slow groups at T2 (e.g., LOX, PAMR1, CDCA8, C1QTNF6, FNDC1, CCDC80, MFSD7, FMO2, SI, SLC26A4).